Riskpilot← Back to searchSign inGet full accessHellerup Healthcare Innovation ApS
APSActiveCVR 17660608Tuborg Havnepark 17, 1. thEngineering activities and related technical consultancy · NACE 7112Est. 19941 employees
Revenue 2025
DKK 301K
-12% vs 2024
EBITDA margin
31.6%
+264% vs 2024
Equity ratio
46.5%
Financial strength
Net profit 2025
DKK 337K
+102% vs 2024
| Revenue | DKK 301K | -12% |
| EBITDA | DKK 95K | +264% |
| Net profit | DKK 337K | +102% |
| Total assets | DKK 443K | +10% |
| Equity | DKK 206K | +2342% |
| Employees | 1 | — |
Legal name
Hellerup Healthcare Innovation ApS
CVR number
17660608
Legal form
Anpartsselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
7. marts 1994
Share capital
DKK 82.200
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er dental konsulentbistand og anden efter ledelsens skøn hermed beslægtet virksomhed.
Address
Tuborg Havnepark 17, 1. th
Phone
+4521433302
Email
arneastrup@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 579 | 291 | 201 | 343 | 301 |
| Staff expenses | -652 | -500 | -508 | -401 | -206 |
| EBITDA | -73 | -209 | -307 | -58 | 95 |
| Depreciation & amort. | -109 | -137 | -55 | -11 | -11 |
| EBIT | -182 | -347 | -363 | -70 | 84 |
| Net financials | 240 | 223 | 300 | 208 | 284 |
| Profit before tax | 58 | -124 | -63 | 138 | 368 |
| Tax | -18 | -35 | -29 | -29 | 31 |
| Net profit | 76 | -89 | -33 | 167 | 337 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 560 | 395 | 282 | 402 | 443 |
| Equity | 409 | 207 | 60 | -9 | 206 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 151 | 187 | 222 | 412 | 237 |
| Total debt | 151 | 187 | 222 | 412 | 237 |
EBITDA margin
31.6%
This company
15.8%
Market median
+100% vs market
20212025
Equity ratio
46.5%
This company
38.2%
Market median
+22% vs market
20212025
Return on equity
163.7%
This company
18.4%
Market median
+790% vs market
20212025
Net profit margin
111.8%
This company
8.1%
Market median
+1280% vs market
20212025
Asset turnover
0.68×
This company
1.12×
Market median
-39% vs market
20212025
Debt / equity
1.15×
This company
0.62×
Market median
-85% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JW Founder | Founder | 1994 |
| Former (1) | ||
AS Chief Executive Officer | Chief Executive Officer | 2000 – 2003 |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
| Chairman | 2000 – 2011 | |
| Board of Directors | 1994 – 2000 | |
| Chairman | 1994 – 2000 | |
| Board of Directors | 2000 – 2004 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2023 | |
| Individual | 20–24.99% | 20–24.99% | 2001 | |
| Individual | 20–24.99% | 20–24.99% | 1997 | |
| Individual | 20–24.99% | 20–24.99% | 1999 | |
| Individual | 50–66.65% | 50–66.65% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Hellerup Healthcare Innovation ApS 
FLAX-SLIM ApSBoard members of Hellerup Healthcare Innovation ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jørgen Walin | Founder | 0 companies |
| Anna Sara Jursic | Chief Executive Officer | 0 companies |
| Søren Narv Pedersen | Chairman | 0 companies |
| Annette Hanne Walin | Board of Directors | 0 companies |
| Mettemaija Munck Rasmussen | Chairman | 0 companies |
| Søren Toubro | Board of Directors | 0 companies |